000 | 01183 a2200349 4500 | ||
---|---|---|---|
005 | 20250513051332.0 | ||
264 | 0 | _c19940519 | |
008 | 199405s 0 0 eng d | ||
022 | _a0140-6736 | ||
024 | 7 |
_a10.1016/s0140-6736(94)90169-4 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKeen, J C | |
245 | 0 | 0 |
_aP-glycoprotein and resistance to tamoxifen. _h[electronic resource] |
260 |
_bLancet (London, England) _cApr 1994 |
||
300 |
_a1047-8 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily B, Member 1 |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aCarrier Proteins _xisolation & purification |
650 | 0 | 4 | _aDrug Resistance |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMembrane Glycoproteins _xisolation & purification |
650 | 0 | 4 |
_aTamoxifen _xtherapeutic use |
700 | 1 | _aMiller, E P | |
700 | 1 | _aBellamy, C | |
700 | 1 | _aDixon, J M | |
700 | 1 | _aMiller, W R | |
773 | 0 |
_tLancet (London, England) _gvol. 343 _gno. 8904 _gp. 1047-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(94)90169-4 _zAvailable from publisher's website |
999 |
_c7908416 _d7908416 |